[LINCOLN, NE, 19 MAY 2020] Adjuvance Technologies announced today that it has been awarded supplemental contract funding from The National Institute of Allergy and Infectious Diseases (NIAID). The funds will be used to evaluate TQL1055, manufactured by Adjuvance, with SARS-CoV2 […]
Adjuvance Technologies Press Releases